Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6409783 | 1.00 | AKR1B1 (0.43) | AKR1B1GAPDH | |
| SCHEMBL128419 | 1.00 | AKR1B1 (0.43) | AKR1B1GAPDH | |
| SCHEMBL1044688 | 1.00 | AKR1B1 (0.43) | AKR1B1GAPDH | |
| SCHEMBL3425314 | 1.00 | AKR1B1 (0.43) | AKR1B1GAPDH | |
| SCHEMBL5987889 | 1.00 | AKR1B1 (0.43) | AKR1B1GAPDH | |
| SCHEMBL29409479 | 0.97 | AKR1B1 (0.42) | AKR1B1GAPDH | |
| Ammonia Solution, Strong SCHEMBL28822860 | 0.97 | AKR1B1 (0.42) | AKR1B1GAPDH | |
| SCHEMBL30664650 | 0.97 | AKR1B1 (0.42) | AKR1B1GAPDH | |
| Alcohol SCHEMBL28228654 | 0.93 | AKR1B1 (0.44) | AKR1B1GAPDH | |
| Phosphoric Acid SCHEMBL5790794 | 0.91 | AKR1B1 (0.37) | AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1970 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260009063-A1 | HIGH-PURITY STEVIOL GLYCOSIDES | PURECIRCLE SDN BHD (MY) | 2026-01-08 | — | — | US | claimed |
| US-12435471-B2 | Wallpaper composition and wallpaper releasing flavorant component by heat | KT&G CORPORATION (KR) | 2025-10-07 | — | — | US | claimed |
| US-12378590-B2 | High-purity steviol glycosides | PURECIRCLE USA INC. (US) | 2025-08-05 | — | — | US | claimed |
| EP-4554408-A1 | CHICKEN-SUBSTITUTE FOOD PRODUCTS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2025-05-21 | — | — | EP | claimed |
| EP-4551583-A1 | HIGH-PURITY STEVIOL GLYCOSIDES | PureCircle SDN BHD (MY) | 2025-05-14 | — | — | EP | claimed |
| WO-2025083657-A1 | LIPID COMPOUND AND COMPOSITION FOR TISSUE-SPECIFIC DELIVERY OF ACTIVE SUBSTANCE | 한국생명공학연구원 | 2025-04-24 | — | — | WO | claimed |
| EP-4215668-B1 | WALLPAPER COMPOSITION AND WALLPAPER FROM WHICH FLAVOR INGREDIENT IS RELEASED BY HEAT | KT & G CORP (KR) | 2025-04-23 | — | — | EP | claimed |
| WO-2025048633-A2 | HIGH-PURITY STEVIOL GLYCOSIDES | PURECIRCLE SDN. BHD. (MY) | 2025-03-06 | — | — | WO | claimed |
| EP-4230060-B1 | SMOKING PRODUCT CONTAINING NOVEL FLAVORING AGENT | KT & G CORP (KR) | 2025-03-05 | — | — | EP | claimed |
| EP-4215063-B1 | NOVEL FLAVORING AGENT, FLAVORING AGENT COMPOSITION, AND PRODUCT COMPRISING SAME | KT & G CORP (KR) | 2025-01-22 | — | — | EP | claimed |
| EP-0983287-B1 | NOVEL GLYCOSYLATED GINKGOLIDE DERIVATIVES, THEIR APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS | SOD CONSEILS RECH APPLIC (FR) | 2003-03-12 | — | — | EP | claimed |
| EP-1289944-A2 | THIOKETALS AND THIOETHERS FOR INHIBITING THE EXPRESSION OF VCAM-1 | Atherogenics, Inc. (US) | 2003-03-12 | — | — | EP | claimed |
| EP-1257565-A1 | MUCIN-1 DERIVED ANTIGENS AND THEIR USE IN IMMUNOTHERAPY | THE AUSTIN RESEARCH INSTITUTE (AU) | 2002-11-20 | — | — | EP | claimed |
| US-20020016300-A1 | Thioketals and thioethers for inhibiting the expression of VCAM-1 | CRABTREE ACQUISITION CO, LLC | 2002-02-07 | — | — | US | claimed |
| WO-2001070757-A2 | THIOKETALS AND THIOETHERS FOR INHIBITING THE EXPRESSION OF VCAM-1 | ATHEROGENICS, INC. (US) | 2001-09-27 | — | — | WO | claimed |
| WO-2001057068-A1 | MUCIN-1 DERIVED ANTIGENS AND THEIR USE IN IMMUNOTHERAPY | THE AUSTIN RESEARCH INSTITUTE (AU) | 2001-08-09 | — | — | WO | claimed |
| US-6143725-A | FOR TREATING VASCULAR DISEASES | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S) (FR) | 2000-11-07 | — | — | US | claimed |
| CN-1260801-A | Novel glycosylated ginkgolide derivatives, their applicated as medicines and pharmaceutical compositions | CONSEILS DE RES S ET D APPLIC (FR) | 2000-07-19 | — | — | CN | claimed |
| WO-1995018145-A1 | CONJUGATES OF HUMAN MUCIN AND A CARBOHYDRATE POLYMER AND THEIR USE IN CANCER TREATMENT | ILEXUS PTY LTD (AU) | 1995-07-06 | — | — | WO | claimed |
| EP-0659768-A2 | Antigen-carbohydrate conjugates and their use in immunotherapy | ILEXUS PTY LTD (AU) | 1995-06-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009063-A1 | HIGH-PURITY STEVIOL GLYCOSIDES | RFT1, TAS2R7, ACAT2 | AKR1B1 432/4885GAPDH 1207/4885 |
| US-20020016300-A1 | Thioketals and thioethers for inhibiting the expression of VCAM-1 | VCAM1, ICAM1, KCNT1 | AKR1B1 308/4885GAPDH 1452/4885 |
| US-12378590-B2 | High-purity steviol glycosides | SI, TAS2R40, TAS2R7 | AKR1B1 1446/4885GAPDH 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.